ArticleArchives of medical science : AMS2022

Clinical outcomes of patients with acute lymphoblastic leukemia receiving the hyper-CVAD regimen and assessment of the risk of hepatitis flares due to hepatitis B virus reactivation after chemotherapy.

Man Fai Law et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.